Lumara Health, Inc.
Quick facts
Phase 3 pipeline
- clindamycin phosphate/butoconazole nitrate · Fungal infections, Bacterial infections
Clindamycin phosphate/butoconazole nitrate is an antibiotic and antifungal combination that works by inhibiting bacterial cell wall synthesis and disrupting fungal cell membranes. - Estradiol transdermal one 90 μL spray · Endocrinology / Women's Health
Estradiol transdermal spray delivers the hormone estradiol through the skin to replace or supplement endogenous estrogen levels. - Estradiol transdermal three 90 μL sprays · Endocrinology / Women's Health
Estradiol binds to estrogen receptors (ERα and ERβ) throughout the body to restore circulating estrogen levels in postmenopausal women. - Placebo transdermal one 90 μL spray
A placebo transdermal spray that delivers no active pharmaceutical ingredient, used as a control in clinical trials. - Placebo transdermal three 90 μL sprays
This is a placebo formulation with no active pharmacological mechanism. - Placebo transdermal two 90 μL sprays
This drug does not have a known mechanism of action.
Phase 2 pipeline
- Danazol Once Weekly · Oncology
Androgen receptor antagonist - Danazol Twice Weekly · Hematology; Immunology; Gynecology
Danazol is a synthetic androgen that suppresses pituitary gonadotropins and has immunomodulatory effects, used to treat conditions involving abnormal bleeding or immune dysfunction.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: